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Abstract
Naloxone hydrochloride, popularly known by the brand name Narcan, is an emergency
treatment used to reverse an overdose on opioid drugs. The CDC reports upwards of 26,000
individuals saved by naloxone between 1996 and 2014 (Centers for Disease Control and
Prevention, 2015). Despite this success rate, those outside of the medical field largely remain
unaware of what naloxone is or how they can use it in an emergency, leading to needless loss of
life. Many studies focusing on naloxone access and education have been unable to offer findings
meant to increase the use and ownership of the drug by lay individuals. To help redress this, the
current study aims to dissect the potential motivations and deterrents to accessing and acquiring
naloxone using the Health Belief Model as a guide. Participants were asked to complete a survey
investigating their previous exposure to, general attitudes about, and intent to access and further
educate themselves about naloxone. The current study seeks to utilize the motivational
framework of the Health Belief Model to better understand the important issue of access to antiopioid drugs. Relevant findings are intended to aid in the pursuit of an efficient and successful
application in the public health domain to increase naloxone possession and decrease deaths
caused by opioid drugs.
Keywords: Health Belief Model (HBM), overdose, drugs, naloxone, public health, opioid
crisis, motivation, health behavior
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Naloxone Education and the Health Belief Model
Naloxone hydrochloride, commonly known by the brand-name Narcan, is an anti-opioid
drug used in the treatment of opiate overdose cases. Narcan has the ability to “reverse the effects
of opioids, including respiratory depression, sedation, and hypotension” (Endo Pharmaceuticals,
2004). This drug is often used by medical personnel and first responders to resuscitate patients in
emergency situations. While Narcan is commonplace in the medical field, awareness is not as
wide-spread within the American public.
There are many medications that the general population lacks awareness of without
consequence; what makes Narcan any different? It is available in most states without a
prescription, meaning that the public has the unique opportunity to play a part in the reversal of
opioid overdoses. Furthermore, medical doctors have voiced their support of public access to
Narcan and see it as an effective, practical treatment for overdose cases (Behar, Bagnulo, &
Coffin, 2018). Despite this opportunity to safely treat and protect members of the community,
many Americans remain unaware of how to obtain and administer Narcan.
The lack of knowledge about anti-opioid drugs is particularly concerning in light of the
ongoing opioid epidemic in the United States. Starting in 2016, the sale and use of drugs such as
heroin, fentanyl, and tramadol began to rise. The next year saw a significant increase in opioidinduced fatalities in 23 states (CDC, 2018). Nearly half the states in the country experienced
extreme and dangerous changes due to the heightened availability of opioid drugs, prompting the
U.S. Surgeon General to release an official advisory “emphasizing the importance of the
overdose-reversing drug naloxone.” While opioid overdoses and related deaths remain at an alltime high, as outlined below, the American public remains largely unaware of what Narcan is
and how it could be used to save a life.

NALOXONE EDUCATION & THE HEALTH BELIEF MODEL

5

The lack of public knowledge regarding Narcan has been demonstrated in both popular
and empirical research. A 2018 IBM Watson study boasts knowledge of the drug in nearly 60%
of participants, however, the focus should be shifted to the significantly lower figures of those
who have purchased the drug and are aware that it does not require a prescription in most states.
Roughly 30% of participants were aware that Narcan could be obtained prescription-free at the
pharmacy. This figure is a closer approximation of individuals who are informed enough to
acquire Narcan. The distinction between awareness of the drug and knowledge of how to get it
becomes important when observing the probability of collecting and eventually administering
Narcan. An empirical study sponsored by the National Institutes of Health (NIH) also collected
similar results. Approximately 65% of participants knew what Narcan/naloxone was, but
knowledge of where to acquire the drug was significantly lower (33%) (Kirane, Ketteringham,
Bereket, Dima, Basta, Mendoza, & Hansen, 2016). These studies are extremely helpful in
identifying the gaps in public education and groups that are most in need of an intervention.
While research has also identified a shortage in pharmacist and health provider knowledge about
naloxone (See Nielsen, Menon, Larney, Farrell, & Degenhardt, 2016; Kirane et al., 2016), the
current study aims to focus on the health behaviors of the general population.
Vulnerable populations and monetary barriers have been a subject of study in many
research projects concerning anti-opioid drugs. A 2018 study from the University of Pittsburgh
School of Nursing provided Narcan administration training and prescriptions for each
participant. All participants in the study were patients at a clinic for the homeless, a population
that is “disproportionately affected by opioid overdoses” (Pietrusza, Puskar, Ren, & Mitchell,
2018). The study reported a statistically significant increase in participant knowledge of signs of
opioid overdose, how to respond to an overdose, and how to deliver a nasal dosage of Narcan.
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While the improvement in education is promising, the researchers also report that only 33%
percent of study participants filled the Narcan prescription in the subsequent week. This low fillrate emphasizes the need to explore the logistical and psychological influences that prevent
individuals from acquiring Narcan.
The current study is critical because it addresses and seeks to understand an issue that has
been largely ignored thus far in psychological literature. It will not only identify the contributing
factors of low levels of naloxone education, but also to provide an understanding of the social
influences that shape these contributors. Additionally, this study will culminate in the
development of future directions for anti-opioid awareness efforts. The ultimate goal of this
study is to increase the health behaviors of possessing and knowing how to use drugs like Narcan
to reduce deaths caused by opioid overdose.
The Health Belief Model (HBM)
The Health Belief Model (HBM) seeks to determine the likelihood of practicing health
behaviors through the observation of various psychological dimensions. Rosenstock, Strecher,
and Becker break down the HBM into a triad of factors including: relevancy of the health issue,
perceived threat, and likelihood of success (Becker, Drachman, & Kirscht, 1974). A
comprehensive review of HBM academic literature published in 1984 reconfigures these
categories in the now commonly used dimensions of perceived susceptibility, perceived severity,
perceived benefits, and perceived barriers. Subsequent alterations of the HBM in later research
have also emphasized the role of self-efficacy in determining an individual’s health beliefs
(Glanz & Bishop, 2010). The four HBM dimensions established in Janz and Becker’s decadespanning meta-analysis in addition to self-efficacy will be used to guide the current research
(Figure 1). All of these perceptions converge to motivate or inhibit a person’s practiced health
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behaviors—including the decision to acquire naloxone. Let us move on to see how these factors
can motivate or prevent someone from taking action in this context.
Figure 1
Health Belief Model Conceptualization for Acquiring Naloxone

Perceived Severity
Beliefs about the severity of an opioid is individually variable. Those who perceive this
event as having severe consequences on their health, safety, or social life may be more
incentivized to take preventative action. However, if an individual does not believe an opioid
overdose has severe and adverse consequences, they may not be motivated to proactively prevent
an overdose.
Perceived Susceptibility
Some individuals may not take steps to prevent opioid overdoses because they are not
addicted to opioid drugs. This perception can also extend to their social circles, such as friends,
family members, and neighbors that the individual assumes are unaffected by opioid use.
Perceived Benefits
Perceived benefits to action can assist in motivating a health behavior. These benefits
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may be personal, for instance, owning naloxone may be advantageous to an individual’s own
health and safety. Benefits can also be more broad, including results such as the betterment of
society or the protection of a friend or family member. The benefits of the drug itself would also
be considered—does it effectively treat the issue? Will it help the person it is given to? Perceived
benefits should outweigh perceived barriers in the pursuit of a health behavior.
Perceived Barriers
Additionally, the negative stigmas regarding drug-users, lack of access to a pharmacy, or
unstable financial status are all examples of perceived barriers an individual may have. Like
opioid addiction, HIV, AIDS, and related conditions carry stigmas that potentially prevent the
seeking of medical assistance. A 2018 study applied the concepts of the Health Belief Model and
demonstrated that the advantages of taking PrEP (Pre-exposure Prophylaxis) were frequently
overpowered by the objective and perceived barriers of participants—preventing their use of the
medication (Felsher, 2018). This finding suggests an important influence for perceived barriers
over health behaviors that may be associated with a controversial group or idea.
Self-Efficacy
The self-efficacy dimension addresses an individual’s confidence in their abilities to
successfully perform a health behavior. In terms of this study, self-efficacy includes confidence
in the ability to use or access naloxone in addition to general first aid and opioid knowledge.
Applying the HBM to “External” Behaviors
An important question to ask about analyzing the HBM in this context is whether or not it
is applicable to a behavior outside of personal consequence. Naloxone ownership has the
potential to be more beneficial for others than the individuals who are purchasing the drug
themselves. The HBM has been empirically applied to behaviors that concern the health of
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others, not just the self. A 2014 randomized controlled trial studied the impact of an HBMguided educational program upon safety and injury knowledge, HBM factors, and applied
behaviors in mothers of young children. In this study, the mother’s development was centered
around their child, and not them personally. Despite this deviation from traditional HBM studies,
there were statistically significant increases in knowledge, perception, and integration into daily
life (Cheraghi, Poorolajal, Hazavehi, & Rezapur-Shahkolai, 2014).
Some may speculate that although the mothers in the experiment are taking health-related
action to benefit others, they may have different motivations due to their close relationship with
their children. However, other HBM studies have been performed that take this same concept
and apply it on a broader, less intimate scale. In a 2019 study, Lynch and Jackson examined the
influence of the Health Belief Model in the context of local gun control policies. Like naloxone
education, this study is in the interest of public health and safety. Researchers found that
perceived risk to loved ones influenced the immediate, situational health behaviors. The study
also revealed that community attitudes toward the policy was more likely to impact any long
term patterns of health behaviors regarding gun control. Thus, community values and helping
behaviors are highly indicative of the ultimate executed health behavior.
This concept is problematic due to the varying levels of prosocial behavior among
individuals. This research must account for the fact that some people may acquire naloxone due
to prosocial motivations, a factor not included in the HBM. This can be remedied by controlling
for the influence of prosocial behavior in the assessment. By testing for prosocial behavior, we
will be able to detect if this attribute is an important aspect of the individual variables that
influence all aspects of the model.
The Current Study
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The objective of the current study is to increase the likelihood of obtaining anti-opioid
drugs like Narcan for preventative use. This correlational study is designed to determine the
strength and importance of various psychosocial mechanisms that influence the acquisition of
anti-opioid drugs. The reported salience of these components can assist in the development of
future educational interventions to increase knowledge of naloxone and eventually decrease the
amount of opioid-related deaths.
Hypothesis
My current hypotheses are based on the aforementioned findings. As a result, it is
predicted that those who score highest for the health belief model factors will have higher intent
scores. This assumption is based on the increased compliance with health behaviors when factors
of the Health Belief Model are salient. Second, it is hypothesized that those who are more
educated about naloxone will a) score higher in HBM factors, and b) higher in intent to fulfill the
health behavior [acquiring the drug]. This hypothesis is rooted in the presumption that those with
more relevant education and awareness have an additional motivating factor to acquire naloxone.
Finally, the study predicts that those who score highly in prosocial behavior will a) score higher
in HBM factors, and b) higher in intent to fulfill the health behavior. As it is the nature of
prosocial behavior to assist others, prosocial behavior should increase perceived benefits to
action for the individual. Consequently, this should result in increased HBM measures overall
and an increased likelihood to acquire naloxone.
Method
Participants
In order to eventually apply this research for use in the real world, the decision was made
to select from the population most commonly affected by opioid overdose. According to a 2017
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meta-analysis conducted by the CDC, American individuals between the ages of 25 to 54
experienced the most dramatic increase in opioid overdose death (CDC, 2017). Because this
group most frequently suffers from the adverse effects of opioids, it was deduced that increased
naloxone possession in the same group would be beneficial. Due to this age group, only
surveying fellow college students would not be conducive to accurate results. Therefore, it was
decided to target an older group of individuals to sample from and adjusted my distribution
accordingly.
Exclusionary factors
For the sake of focusing this study on the knowledge of the general public, health
providers and first responders will be excluded from the study. The chance of prior exposure to
naloxone education could skew the results if their data were included in the analysis.
Materials
Measures
There is currently an absence of research that has observed naloxone use through the
application of the HBM, so a new researcher-generated measure was used in this study.
However, there is an abundance of research applying the HBM to other behaviors, so the
questionnaire was modeled after empirically tested and validated measures.
The present questionnaire consisted of a short demographic survey, a pre-questionnaire
with 5 items, a main section with 31 items, and a final post-questionnaire stage. The prequestionnaire is designed to measure prior knowledge and experience with naloxone. Although
not directly related to the HBM, this exposure measure can indicate our sample’s relationship to
other empirical data, thus indicating whether or not we had a representative sample.
After the first section is completed, participants are presented with a short informational
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paragraph defining some medical terms and products that may appear in the next section. This
allows for more wholesome and accurate responses regardless of the possession of prior
knowledge about Narcan. The next section is the HBM questionnaire consisting of 6 parts: 5
items for risk susceptibility, 5 items for risk severity, 5 items for benefits to action, 5 items for
barriers to action, 5 items for self-efficacy, and 6 items for prosocial behavior. Items to measure
each of the HBM factors were researcher-generated, but guided by multiple well-established
HBM studies (See Becker, et al., 1974; Champion, 1999; Jones, Jensen, Scherr, Brown, Christy,
& Weaver, 2015). An HBM composite score was generated by combining all scores of the 5
individual variable scores for the model. Items 9, 21, and 27 (See Appendix A) were adapted
from the Generalized Self-Efficacy Scale (Schwarzer & Jerusalem, 1995). The pro-social
behavior section was adapted from the Helping Attitudes Scale (HAS) (Nickell, G., 1998).
In the post-questionnaire, four questions were asked to estimate each participant's intent
to acquire the drug, learn more about it, and spread the information. A combination of these four
questions made up an “intent” composite score. Intent is essential to this research because it is a
reliable predictor of behavior (Sheeran, 2002). A copy of the complete questionnaire is included
in the appendices.
Procedure
A recruitment message (Appendix B) and a link to the USD Qualtrics survey was posted
on Facebook. A short summary of the purpose of the study was included as part of this message.
The message contained a statement that stated that the survey was voluntary and available to
those 18 years or older.
Clicking on the survey took participants to the first page of the Qualtrics survey. In order
to move into the main part of the questionnaire, participants were required to read and agree to
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the departmental informed consent document. If the participant agreed, they were taken to the
first section of the questionnaire.
At the end of the study, participants were thanked for their time and provided with links
to helpful information if they wanted to learn more about naloxone or the opioid crisis in the US.
The duration of the survey was roughly 10 minutes.
Results
Preliminary Analyses
The current research consisted of a sample of 85 participants, two of which were
excluded from the final study due to their medically-related occupations. The majority of the
participants were female (80%), while male participants only made up 20% of the sample. The
racial makeup of the sample included 87% White participants, 1% American Indian or Alaska
Native participants, 6% Asian participants, 2% Native Hawaiian or Pacific Islander participants,
and 4% designated ‘Other’ participants.
A vital part of this research involves looking into the participants’ familiarity with
naloxone before taking the survey. Only 2% of participants claimed to be extremely familiar
with the drug prior to participation. In contrast, 49% of participants indicated that they were not
at all familiar with the drug. This percentile is slightly higher than the 41% in IBM Watson’s
study and 35% in Kirane’s study that did not know what naloxone was. However, the lower
percentage in Kirane’s study could be due to the sampled population which resided in an area of
high opioid use (2016). A complete representation of familiarity with naloxone is shown in
Figure 2. Of those who indicated a minimum of slight familiarity with naloxone, 2% learned
about it from personal experience, 7% from a medical professional, 7% through work, 5%
through school or an educational program, 31% through media exposure, 2% from a friend, and
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8% from other sources. In terms of exposure to the drug, 2% of the sample has been in
possession of naloxone at some point in the past, while 96% have never owned it. All
participants in the sample answered that they have never had to administer naloxone to someone
else. Only 1% of the sample had naloxone administered to them in the past.
Figure 2
Familiarity Rankings for Naloxone

Age Groups
To check for significant differences between age groups, due to the reported age group
differences from IBM Watson’s 2018 study and Kirane’s 2016 study, participants were split into
6 age categories and compared through a one-way ANOVA. Participants ranging from 18 to 65+
years old acted as participants in the current study. The majority of participants fell between 4554 years old (63%). A series of one-way ANOVAs revealed no significant differences between
the age group in all measured variables apart from prosocial behavior, F(5,70) = 7.403, p = .000.
Post hoc comparisons using the Tukey HSD test revealed that the mean prosocial behavior score
for the 18-24 age group (M = 17.22, SD = 4.09) score was significantly higher than both the 4554 (M = 11.92, SD = 3.09) and 55-64 age groups (M = 10.10, SD = 2.51). These tests also
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indicated that the mean prosocial behavior score of the 25-34 age group (M = 18.50, SD = 6.61)
was similarly higher than the means of the 45-54 and 55-64 age groups.
Education
Training and educational exposure have also been linked to heightened awareness and
motivations to handle opioid overdoses (Behar, Santos, Wheeler, Rowe, & Coffin 2015). To see
if these educational differences had influence over the studied variables, a one-way ANOVA was
conducted to compare each educational group. The highest level of education for the participants
ranged from High School Graduate to Doctorate Degrees. Participants with four year degrees and
professional degrees made up 41% and 36% of the sample, respectively. A one-way ANOVA
indicated a significant difference in risk severity between education groups, F(6,67) = 3.522, p =
.004. The mean score for those with a Professional degree (M = 10.30, SD = 3.05) was
significantly lower than those with a 2 year degree (M = 16.33, SD = 3.21) or a 4 year degree (M
= 12.00, SD = 3.10). To determine any differences in perceived barriers in educational groups, a
one way ANOVA was run, F(6,69) = 2.941, p = .013. A subsequent Tukey HSD test revealed
that those with a doctorate (M = 26.33, SD = 5.03) scored significantly higher than all other
educational groups for perceived barriers. There were no other significant differences between
educational groups for any other of the measured variables.
Composite Scores
Average scores for each individual variable were calculated. Benefits to Action, Barriers
to Action, Self-Efficacy, Risk Susceptibility, and Risk Severity were all scored on a scale
ranging from 5 to 35. Scores closer to 5 indicated higher values of the studied variables, while
scores closer to 35 indicated a weak motivation. To simplify, scores less than 15 indicated high
affinity for the variable, scores between 15 and 25 were medium, and values above 25 were
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considered low. On average, the studied sample ranked high in perceived benefits and risk
severity, medium for barriers to action and self-efficacy, and low in risk susceptibility. The
overall HBM composite score was based on a combination of the five previously mentioned
variables and given a score ranging from 30 to 175. The overall HBM composite scores
collected had an average of 96 (M = 96.16, SD = 13.04). This score would fall in the moderate
strength for all combined HBM factors. Prosocial behavior was calculated from a sum of 6
questions on a scale of 6 to 42. On average, the participants scored as high in prosocial behavior.
Lastly, the intent composite summed the results from the items described in the postquestionnaire. This score was measured on a scale from 4 to 28. The average participant score
indicated high levels of intent. Internal consistency was calculated using average inter-item
correlations for each variable instead of Cronbach’s alpha due to the small number of factors
(Table 1).
Table 1
Average Scores for HBM Factors, Prosocial Behavior, and Intent
M

SD

Average Inter-Item Correlation

Benefits to Action

14.45

4.39

.2883*

Barriers to Action

17.33

4.61

.1429

Self-Efficacy

20.72

4.51

.2086*

Risk Susceptibility

26.09

3.98

.2105*

Risk Severity

11.88

3.57

.0925

Prosocial Behavior

12.68

4.01

.2379*

Intent

14.67

4.24

.4333*

Note. *Items fall in ideal range between .15 and .50.
Main Analyses
The relationships between factors of the HBM, Prosocial Behavior, Familiarity, and
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Intent to complete the health behavior were evaluated using Pearson correlations to determine
the strength and significance of their associations.
Benefits to Action
Multiple results represented in Table 2 demonstrate important relationships for benefits to
action. According to the hypotheses, perceived benefits were predicted to have positive
significant relationships with familiarity, prosocial behavior, and intent. As shown in the table,
perceived benefits to action have a weak, positive correlation with familiarity with naloxone.
Understandably, perceived benefits demonstrated a similar relationship in the opposite direction.
Higher benefits to action scores were also weakly associated with higher perceptions of risk
susceptibility. Additionally, measures of prosocial behavior were weakly correlated with
perceived benefits to action. Intent as measured by the survey also held a weak, but positive
correlation with benefits to action. Benefits to Action scores were not significantly correlated
with self-efficacy or risk severity.
Barriers to Action
The completed Pearson correlations also indicated significant relationships for the
barriers to action variable (Table 2). This study hypothesized a significant inverse relationship
between perceived barriers and the measured variables. Perceived barriers had a moderately
strong negative correlation with naloxone familiarity. As mentioned previously, barriers to action
and benefits to action were weakly negatively correlated with one another. Furthermore, selfefficacy also had a weak, but significant negative relationship with perceived barriers. Barriers to
action were additionally weakly negatively correlated with beliefs of risk susceptibility. Higher
barriers to action scores were also weakly associated with lower estimations of prosocial

NALOXONE EDUCATION & THE HEALTH BELIEF MODEL

18

behavior and intent to acquire naloxone. There were no significant relationships between
perceived barriers and risk severity.
Table 2
P Values for Two-Tailed Pearson Correlations of HBM Factors and Related Variables
Variable

1

2

3

4

5

6

7

8

1. Familiarity

-

.375**

-.537**

.495**

.254*

.114

.149

.226*

2. Benefits to
Action

.375**

-

-.415**

.181

.252*

.182

.388**

.350**

3. Barriers to
Action

-.537** -.415**

-.159

-.365**

-.289*

4. Self-Efficacy

.495**

.181

-.323**

-

.235*

.045

.234*

.315**

5. Risk
Susceptibility

.254*

.252*

-.340**

.235*

-

-.045

.036

.203

6. Risk Severity

.114

.182

-.159

.045

-.045

-

.479**

.103

7. Prosocial
Behavior

.149

.388**

-.365**

.234*

.036

.479**

-

.209

8. Intent

.226*

.350**

-.289*

.315**

.203

.103

.209

-

-

-.323** -.340**

Note. **. Correlation is significant at the 0.01 level (two-tailed).
*. Correlation is significant at the 0.05 level (two-tailed).
Self-Efficacy
Based on the assumptions of the Health Belief Model, higher efficacy scores were
predicted to coincide with higher intent to acquire naloxone. Similar to the two previous
variables, the Pearson correlations indicated a moderate positive correlation between selfefficacy and familiarity with naloxone. Self-efficacy also demonstrated a weakly negative
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relationship with perceived barriers to action. Self-efficacy also had a significant and weakly
positive correlation with risk susceptibility. A Pearson correlation also demonstrated a weak
positive correlation with prosocial behavior. Tests additionally identified a significant positive
correlation between self-efficacy and intent Self-efficacy did not demonstrate any significant
correlations with benefits to action or risk severity (Table 2).
Risk Susceptibility
It was hypothesized that those who believe that they are more likely to be affected by an
opioid overdose would be motivated and thus possess higher intent to purchase a dose of
naloxone. A Pearson correlation found a weak positive correlation between risk susceptibility
and familiarity with naloxone. Additionally, correlations revealed a weakly positive relationship
between risk susceptibility and benefits to action. A Pearson correlation also demonstrated a
weak negative correlation between risk susceptibility and perceived barriers to action. Tests also
indicated a significant weak positive correlation between risk susceptibility and self-efficacy.
Risk susceptibility was not significantly correlated with risk severity, prosocial behavior, or
intent (Table 2).
Risk Severity
Following the ideas outlined by the HBM, belief in severe consequences if naloxone was
not used would be hypothesized to motivate compliance with the health behavior. A Pearson
correlation demonstrated a significant moderate positive correlation between risk severity and
prosocial behavior. Risk severity did not demonstrate significant correlations with familiarity,
perceived benefits, perceived barriers, risk susceptibility, self-efficacy, or intent (Table 2).
HBM Composite Scores
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HBM composite scores were generated by combining the scores of perceived benefits,
perceived barriers, self-efficacy, risk severity, and risk susceptibility. Perceived barriers were
reverse coded because they are a limiting factor, while the other variables encourage a health
behavior. A Pearson correlation found a significant positive correlation between the HBM
Composite Score and intent to complete the studied health behavior (Table 3). An additional
Pearson correlation found a significant positive correlation between the HBM Composite Score
and familiarity with naloxone (Table 3). The HBM Composite was also found to have a strong
positive correlation with prosocial behavior (Table 3).
Other Correlations
A Pearson correlation found a significant positive correlation between familiarity and
intent scores. Prosocial behavior was found to not have a significant correlation with either intent
(p = .072) or familiarity (p = .200).
Table 3
P Values for Two-Tailed Pearson Correlations of Composite Scores
Variable
HBM Composite

HBM Composite

PB Composite

Intent

Familiarity

1

.507**

.467**

.594**

Prosocial Behavior

.507**

1

.209

.149

Intent

.467**

.209

1

.226*

Familiarity

.594**

.149

.226*

1

Note. **. Correlation is significant at the 0.01 level (two-tailed).
*. Correlation is significant at the 0.05 level (two-tailed).
Discussion
The results of this study revealed several important relationships between the Health
Belief Model and naloxone possession. Additional data helped to expand a growing body of
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research on the public’s understanding and attitudes regarding anti-opioid drugs. Half of the
sample was indicated little to no awareness of naloxone and its uses. This value speaks to the
significance of unawareness of anti-opioids in the American public. Furthermore, of those who
were familiar with naloxone, the majority learned about the drug through exposure to television,
movies, and books, while a very small percentage gained their knowledge from a medical
professional. As this knowledge is not being acquired through reputable channels, there is the
risk of stigma and sensationalization of overdose prevention and anti-opioid drugs. The lack of
individuals who learned about naloxone from a medical professional demonstrates a shortage of
educational opportunities and interventions that should already be occurring in the healthcare
field.
The strongest relationships between the individual factors of the HBM, prosocial
behavior, familiarity, and intent were between familiarity and barriers to action, familiarity and
self-efficacy, benefits to action and barriers to action, and risk severity and prosocial behavior.
Although each of the individual HBM factors demonstrated important relationships, perceived
barriers had the most salient relationships with intent, prosocial behavior, and incoming
knowledge. These findings are consistent with those of Felsher’s (2018) study on patient
reluctance of starting on PrEP. It is logical that this relationship would exist for a controversial
issue like opioid use which may have more barriers preventing action than more normalized
health behaviors. Future attempts to increase naloxone ownership should pay particular attention
to minimizing perceived barriers to accessing the drug. Some potential ways of executing this
would be through educational programs, financial support, or through social initiatives that seek
to minimize the stigma associated with drug use.
The HBM Composite score was significantly correlated in a moderate, positive direction

NALOXONE EDUCATION & THE HEALTH BELIEF MODEL

22

for prosocial behavior, familiarity with naloxone, and intent to complete the health behavior.
This result is important because it supports Hypothesis 1: HBM motivators will be associated
with higher intent. Hypothesis 2 was partially supported. Familiarity with naloxone had a
moderately strong positive relationship with overall HBM score. However, the results only
supported a weak positive relationship between familiarity and intent. Finally, Hypothesis 3 was
partially supported. Prosocial behavior displayed a moderately strong positive relationship with
total HBM scores but held no significant relationship with intent. Of the four variables
compared, the HBM composite held the most and strongest correlations with the other variables.
These results support the importance of each of the motivators outlined by the HBM upon
multiple factors that encourage the acquisition of naloxone.
Potential Limitations
There were some notable limitations to this research. Primarily, the sample utilized for
collecting data was a convenience sample. The participants were mainly white females between
the age of 45 and 54. Additionally, many of the participants were local, California residents.
California is a state with good Samaritan overdose protection laws, which may influence
participants’ motivations and behaviors during an overdose situation . As a result of this
arrangement, the data may not apply to the larger United States population.
There was also an element of control that was sacrificed by conducting this survey
remotely. The Qualtrics survey was open for the period of one week, but participants could take
it when and wherever they wanted. Therefore, a controlled environment could not be confirmed
for all participants.
This research was also conducted during the Corona Virus pandemic. The heightened
stress and focus on a different medical issue may have swayed participant responses. As this
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study was also the first of its kind, further replications and adjustments to procedure and surveys
are required to fully explore the complicated nature of this issue.
Broader Implications
This exploratory study could potentially help to shape further research on anti-opioid
medications, develop programs that operate on these findings, or even help to guide future
legislation on the availability and public knowledge of Narcan. By determining which
component(s) of the Health Belief Model hold more weight in the topic of Narcan education, we
can model future efforts and interventions with these dimensions in mind. A more thorough
understanding of the American public’s motivations and limitations to education about Narcan
can help to mold a more effective approach to address this issue. The ultimate goal of all of this
research and increased education is to counteract the amount of deaths caused by opioid
overdoses in the United States. A more educated and capable population would be more prepared
to aid in the situation of an overdose—saving lives in the process. Of course, ideally, the use of
narcotic drugs would be the favorable behavior to correct, but drug addiction is a complex and
multifaceted phenomenon; more time and research are needed to address this deeply-rooted
issue. In the meantime, however, prevention and education are the best tools we have to fight the
opioid epidemic from a psychological perspective.
The positive impact of this research is not only confined to anti-opioid drugs like Narcan.
Hopefully, the motivational aspects discerned from the data can assist applied psychologists in
the adaptation of programs that help prevent or treat other types of overdoses (or similar
behavior). Reaching beyond drug addiction and medical intervention, the factors influencing
individual’s health behavior can ideally provide clues and guidance for the involvement of the
public in other controversial health issues. Furthermore, this study can hopefully contribute to
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the growing body of research of the HBM and the operation of its dimensions in various areas of
medicine.
In order to ensure the validity and generalizability of these findings, further research is
required. This study did not address the potential benefits of combined dimensions of the HBM
in the encouragement of Narcan knowledge and possession. Further correlational studies and
experiments must be conducted in order to detect any interactions between the dimensions of the
HBM. Furthermore, a longitudinal aspect could be added in order to investigate the endurance of
intended health behaviors. A copy of the post-test questionnaire could be administered to the
participants again six months or one year after initial testing. This will allow us to investigate
memory and time as potential barriers to Narcan education.
Ultimately, it is my hope that doctors, pharmaceutical companies, and other health
professionals use the findings of this research to tailor their discussion of Narcan with their
patients. Their involvement will create a more direct line of communication with patients that
has been shown to be associated with an increase in executing a desired health behavior.
Conclusion
Despite the opioid epidemic, many Americans are unaware of how to act in the event of
an overdose. Naloxone is a widely available drug that can reverse these effects if delivered in a
timely manner. Although naloxone does not require a prescription or specialized medical
training, few outside of the medical field own doses of this life-saving medication. An
exploratory questionnaire was distributed to discern the relationship of various motivational
factors in the acquisition of anti-opioid drugs. Results from this survey demonstrate a prominent
lack of knowledge about naloxone. Correlational data supports a positive relationship between
the sum of Health Belief Model factors and intent to purchase naloxone. Data also revealed a
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significant and positive relationship between the HBM factors and prosocial behavior measures.
Positive correlations were also demonstrated between naloxone familiarity and HBM factors.
These outcomes support the influential nature of the Health Belief Model in determining actions
regarding anti-opioid drugs. Prosocial behavior and previous knowledge also demonstrated
important relationships with intent. Moving forward, the Health Belief Model, paired with extra
attention to education and encouraging prosocial acts, may be used to formulate a new public
health approach to encouraging ownership of naloxone.
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Applications: Increasing Naloxone Awareness
A Literature Review of Public Health Initiatives & The War on Drugs in the Context of the
Health Belief Model (HBM)
Introduction
With the information from the previous study, we can begin to conceptualize a public
health initiative based on the components of the Health Belief Model. To do this, it is vital to
have a basic understanding of the historical use and success of public health initiatives in the
United States. Previous and current anti-drug movements have relied heavily on scare tactics and
seek to achieve complete eradication of drugs. However, through the exploration of the
effectiveness of these campaigns in concert with the previous research on the Health Belief
Model, it is more feasible to begin promoting a system centered around the HBM to reasonably
deal with the country’s current issues.
Historical Background
There is undoubtedly controversy and stigma surrounding drugs and drug use in the
United States. This climate inevitably impacts any efforts of the American public to promote
naloxone ownership and limit the amount of annual deaths by opioid overdose. While there have
been various levels of involvement in the control of drugs since the establishment of the United
States, the more draconian policies did not begin until Ronald Reagan’s presidency. This is what
is popularly considered to be the start of the American “War on Drugs”. The heightened
regulation of substances and related punishments were enforced by a combination of legislation,
social movements, and the establishment of governmental departments, such as the Drug
Enforcement Administration (DEA) (War on Drugs).
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As mentioned previously, American government and society are theoretically aiming for
complete abstinence from drug use. This is one of the crucial challenges to promoting the
ownership of anti-opioid drugs. Other harm reduction, or what Drucker and Clear refer to as
“drug maintenance”, initiatives have experienced similar pushback (1999). Due to this attitude of
complete opposition instead of one of assistance and maintenance, the current response to the
opioid crisis in the United States is lacking in its success. In order to re-evaluate and correct the
approach to this issue through the promotion of naloxone ownership, we must educate ourselves
about the successes and failures of past drug campaigns. This can provide insight for the creation
of practical and accessible solutions that utilize previously established systems and information
to address the opioid crisis from a different perspective. Instead of expecting the American
public to say “just say no”, we should prepare them to say “we are ready and able to help”.
Public Health Initiatives
When analyzing the success of past public health initiatives, it is important to
acknowledge the role of public service announcements (PSAs) and similar campaign
commercials. These ads act as the prominent feature for many past public health initiatives in the
United States (Palmgreen & Donohew, 2003). Due to the large audience that these campaigns
reach, it is vital to have a thorough understanding of how they operate to influence health
behaviors. The popularity of these PSAs is evidenced by the collective memory of famous antidrug campaigns, such as Partnership for a Drug-Free America’s This is Your Brain on Drugs ads,
the CDC’s Tips From a Former Smoker series, and Michael Jordan’s “Stop it, get some help”
PSA, to name a few. Despite their prevalence in American society, these ads have failed to
accomplish their purpose.
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The American government has acknowledged the ineffectiveness of its previous
campaigns against drugs. In a 2006 report from the Government Accountability Office,
researchers examined the success of the National Youth Anti-Drug Media Campaign. This $1.2
billion dollar endeavor proved to be ineffective in discouraging drug use in American youth. The
report even addresses the possibility of a “boomerang effect”, meaning that the campaign may
have resulted in higher levels of youth involvement with drugs. In 2012, Magura and associates
performed a meta-analysis of the GAO report and program itself. This research concluded that
the National Youth Anti-Drug Media Campaign failed to accomplish its goals, but hesitated to
agree with the presence of a boomerang effect. This begs the question: what exactly has resulted
in such failures for these health initiatives? Many of these anti-drug campaign ads have a
similarity which is most likely their downfall—an overzealous use of fear.
Fear Appeals
The use of scare-tactics in anti-drug movements is problematic due to the empirical
evidence that cites its ineffectiveness. In Keller’s 1999 experimental studies, it was demonstrated
that scare tactics were only successful for individuals who already practiced whatever health
behavior was being promoted. Alternatively, the research showed that those who did not already
practice this behavior had a negative correlation between level of fear and persuasion to
complete the behavior. Furthermore, a 2015 meta-analysis of the effectiveness of fear appeals
references the Health Belief Model and other psychological theories when claiming support for a
more diversified approach to persuasion. At a bare minimum, researchers suggest that appeals to
fear should operate in tandem with efficacy-reinforcement in order to be effective (Tannenbaum,
Hepler, Zimmerman, Saul, Jacobs, Wilson, & Albarracín, 2015). However, despite the
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overwhelming amount of evidence demonstrating the failures of scare tactics, they are still used
in many drug prevention campaigns; including those for naloxone.
Current Media Approaches to Naloxone Promotion
When searching the phrase “naloxone PSA” on YouTube, a total of 51 videos populate—
a small number considering YouTube’s illustrious library of content . Searching the phrase
“Narcan PSA” produces significantly more results, but both searches yield the same top five
videos. We can use these clips to gain insight to the current approach to naloxone public service
announcements and their effectiveness. To demonstrate this, short descriptions of each video will
be provided along with an analysis of their use of scare tactics as well as utilization of the HBM
factors to encourage naloxone ownership.
Video 1: Nasal Narcan PSA, Stoughton Police
The most popular video, with 74,000 views, opens with ominous music and text overlaid
on a black screen with the prior year’s drug-related death toll in Massachusetts. This is a telling
indicator for the remaining content of the video. Examples of scare tactics used in the video
include a hysterically crying mother, loud police sirens, and images of graveyards, drugs, and
needles. The PSA makes an appeal to risk susceptibility by demonstrating a mother dealing with
the aftermath of her son’s overdose. By using a familiar relationship between a parent and child,
the video creates a more generalizable message. The video primarily focuses on portraying risk
severity associated with opioid overdose. The subject of the video is shown to be unconscious
and unresponsive with blue lips and bloodshot eyes. The previously mentioned fear imagery also
operates as a reminder of risk severity. Benefits to action are not as obvious within the PSA. The
primary benefit to the mother calling 911 is the arrival of emergency services, while the benefit
to their arrival is the resuscitation of the patient. Barriers to action are also not highly apparent in
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the video. Self-efficacy in regards to intervening during an overdose is not reinforced because
the only individuals interacting with the overdose-reversal drug are the first responders. In
summary, this PSA relies mostly on scare tactics stereotypically associated with campaigns
against drugs. While risk severity is communicated through the video, there is no demonstration
of how to use naloxone as a bystanding citizen. The video does provide a website and phone
number for obtaining Narcan, but this is only at the end of the four minute PSA.
Video 2: Good Samaritan PSA (Heroin Overdose/Narcan), Drug Free Manatee
The second most-viewed naloxone PSA takes a slightly different approach to the concept
of opioid overdoses. While it portrayed the consequences of an overdose in a similar manner to
the first video, this PSA primarily focuses on the Good Samaritan Laws in Florida. Despite its
differing orientation, scare tactics are still employed frequently in the 30 second ad. Images of a
used needle, yelling voices, and statistics about overdose deaths are utilized to make the audience
aware of the negative consequences of drug use. While it is not clear what the relationship is
between the man who alerted authorities and the woman who overdosed, it can be inferred that
they are friends, or at least acquaintances. This familiar social connection may prompt the
audience to think about friends that may be susceptible to an opioid overdose. Like the first PSA,
this video emphasizes risk severity. The unconscious woman with blue lips, an audibly racing
heartbeat, medical equipment, and flashing lights of emergency vehicles reinforce the danger of
the situation. Barriers to action are demonstrated in this video via the argument the friends have
over whether or not to call the police. Concerns about being cited for drug possession can be an
influential barrier to taking action during an overdose. This ad takes a more direct approach to
benefits to action by having the police officer tell the man that called 911 that this action saved
the woman’s life. Self-efficacy is promoted by showing the man playing an active role in the
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situation. However, there is no emphasis on self-efficacy specifically related to naloxone,
because there is no on or off-camera references to the use of an overdose-reversal drug. Overall,
this PSA is helpful in educating Floridian citizens about the legal protections they are afforded
when intervening with an overdose. While this is a step in the right direction, the PSA fails to
recognize the ability for citizens to administer naloxone; a health behavior that could potentially
save a life while emergency services are transported to the scene.
Video 3: PSA: Naloxone : 30, Maryland Department of Health and Mental Hygiene
The third video focuses on a stereotypical drug user: a gloomy teen with smudged
makeup wearing all dark clothes. While there are fewer scare tactics present in the PSA, the
parent’s whispered discussion and the daughter’s collapse to the ground call attention to the
danger associated with opioids. Similar to the first video, this PSA utilizes the parent-child
relationship to increase perception of risk susceptibility. Furthermore, the voice-over indicates
that prescription opioids can also cause addiction; while some individuals may not feel
susceptible to recreational drugs, taking prescribed medication is a common experience that
many can relate to. Risk severity is portrayed through the daughter’s loss of consciousness to
signify the overdose. This PSA works to actively reduce barriers to action by demonstrating that
it is possible to have overdose-reversal drugs in the household and by working to dismiss the
harmful stigma surrounding drug use. The daughter’s return to consciousness after her mother
administers naloxone is a clear marker of benefits to action. Self-efficacy is a prominently
featured issue in this PSA. The parents’ quick responses, knowledge and ownership of the drug,
and successful administration all operate as a successful model for the audience. This PSA is
successful in appealing to all aspects of the Health Belief Model. It could be further improved by
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demonstrating how to assemble and administer doses of naloxone and using costumes or actors
that do not fit the stereotypical category of “drug user”.
Video 4: Narcan Administration PSA, Whitestown Fire Department
The fourth video takes an instructional approach to naloxone and drug overdoses. The
local chief of the fire department speaks about naloxone, opioid addiction, and overdose during
the PSA. Scare tactics are limited to mentions of possible death as a result of opioid overdose as
well as the imagery of an unconscious victim with drugs, a needle, a home-made tourniquet, and
vomit. Like the Good Samaritan PSA, risk susceptibility is communicated through the common
relationship of friendship. The friends that find the overdose victim could easily be anyone. One
barrier mentioned in the PSA is naloxone’s inability to “cure” addiction. As the drug is not a
complete solution, but simply an aid in the direction of rehabilitation, individuals may find
themselves more reluctant to acquire it. Additionally, the ER doctor speaking in the video states
that naloxone and other anti-opioids will not counteract the effects of other types of drugs. The
PSA does manage to counteract some of the negative associations of drug use by referring to
addiction as a disease, not an intentional or destructive choice. In terms of benefits to action, the
Fire Chief repeatedly references the usefulness and effectiveness of naloxone. Arguably, selfefficacy is the main focus of this PSA. The reenactment demonstrates the friends following firstaid protocol, calling 911, administering a dose of Narcan, and moving the man to a recovery
position. The PSA also includes discussion of the three types of naloxone kits that can be
purchased at a pharmacy—including assembly and administration instructions. This video is a
prime example of what more anti-drug PSAs should look like: information- and efficacy-focused
without unnecessary scare tactics. That being said, the video only has 1,360 views (as of
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November 9, 2020). Despite the positive attributes of this PSA, it is not reaching a large enough
audience to have a thorough impact on American society.
Video 5: PSA: Naloxone : 15, Maryland Department of Health and Mental Hygiene
This public service announcement is an abridged version of Video 3. All points
mentioned for the full version still apply to this video (see above).
Naloxone PSAs: Debrief
As demonstrated above, many of the currently available PSAs for naloxone are overly
reliant on scare tactics. The ads demonstrate the usefulness of the drug, but this can easily be lost
within the overt death and fear-related messages. The PSAs that were successful in most fronts,
such as the Whitestown Fire Department PSA, were lacking in their outreach capabilities. Future
development of naloxone PSAs should use appeals to the HBM as opposed to falling back onto
the traditional methods used by anti-drug campaigns.
Shifting to a HBM-Based Approach
Looking back to our Health Belief Model, we can see that a fear-based approach only
really addresses the perceived severity element. This is problematic because the questionnaire
data as well as a growing body of research indicates that all five factors are relevant in the
determination of a health behavior. As seen for the issue of anti-opioid knowledge and
ownership, barriers to action are especially significant. Due to this significance, barriers to action
should be given specific attention, but all of the other factors must be addressed as well. As
further research is conducted, the proposed plan can be altered by putting emphasis on any of the
five factors of the HBM based on a community’s needs and relevant trends.
Perceived Susceptibility
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In terms of increasing the American public’s perceived susceptibility to opioid overdose,
there are a variety of possible approaches to take. One possible tactic would involve the
increased awareness of “average” people who develop drug addictions. What many fail to
recognize is that there are several types of opioid drugs that are legally prescribed by a medical
professional. Therefore, it is entirely feasible that an addiction could develop over the course of
recovery from a surgery or other common medical issue. What is essential about increasing
perceived susceptibility is getting Americans away from the mindset that addiction only happens
to a specific “other” group of people. It is a common issue that no one is automatically excluded
from. Furthermore, the publication of rates of addiction, opioid use, opioid overdose, and opioidrelated fatalities could be utilized to promote ownership of naloxone by appealing to individuals
who are more likely to be influenced by data and numbers.
Perceived Severity
To increase the perceived severity of opioid addiction, we can take a modified approach
to current anti-drug campaigns. However, instead of using scare-tactics to threaten individuals
into acquiring naloxone, these campaigns can appeal to severity through the use of a different
approach. Kingsbury’s 2015 study on heavy drinking intentions explored the impact on behavior
when individuals are presented with a health gain or loss or, alternatively, a social gain or loss.
Researchers found that those presented with social loss or health gains drank the smallest amount
of alcohol (Kingsbury, Gibbons, & Gerrard, 2015). We can apply this concept of appealing to
social consequences and health benefits in future PSAs for naloxone. For example, ads could
present the social consequences of not having naloxone on hand or by emphasizing the healthrelated advantages or being prepared for an opioid overdose. This is a more empirically-
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supported method than relying on historically ineffective fear tactics to address naloxone
ownership.
Benefits to Action
Increased understanding of benefits to action can be promoted through PSAs, medical
interactions, and social discourse. This could involve sharing personal stories of gratitude and
recovery to demonstrate how someone’s life was turned around after they were given a dose of
naloxone. Additionally, figures demonstrating the number of lives saved by naloxone could
provide concrete evidence of its success rate. PSAs could also present naloxone ownership as an
opportunity to assist a friend, family member, or neighbor and bring peace of mind for the
individual who owns it.
Barriers to Action
There are multiple dimensions that must be considered in order to reduce barriers to
action in the United States. Four substantial barriers at the forefront of this issue are social
stigma, pharmaceutical knowledge, legal barriers, and monetary barriers. Social stigma is a
significant issue ingrained within the American societal cognition. It is difficult to address this
issue in its entirety due to its overarching presence, but there are steps we can take to reframe the
societal approach to drug overdose. PSAs should actively make an effort to not demonize drug
users or paint them in any subhuman context. The lack of pharmaceutical and medical
professionals that are well-versed in anti-opioids and overdose prevention also presents a major
complication. As of 2016, Australia legalized the sale of naloxone from pharmacies without a
prescription. Despite naloxone being theoretically available to anyone who asks for it, there were
many complications that prevented this from being the case. In a survey of nearly 600 Australian
pharmacies, the majority of reporting pharmacists expressed reluctance in their ability to provide
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education about the drug and similarly did not feel capable of identifying customers who needed
naloxone. Most alarmingly, only 41% of participating pharmacists expressed a willingness to
provide naloxone over the counter (Nielsen, Menon, Larney, Farrell, & Degenhardt, 2016). This
indicates that more than half of all pharmacies would turn someone away that asked for a legal
drug. This creates barriers which are typically uncontrollable for the average citizen. As
Australian regulations and social climate as addressed in the study are comparable to the United
States, we can apply the same conclusions to our own society. Furthermore, states that lack
legalized ownership of naloxone and Good Samaritan laws also act as barriers to action. Through
increasing education about naloxone in all fields, hopefully state and federal governments will
recognize the advantages to legalizing naloxone throughout the country. Lastly, monetary
barriers may also limit individuals from obtaining the drug. Many organizations have made
efforts to counteract this barrier by providing free or discounted overdose kits (which include
naloxone) to drug-users, their friends, and families (National Harm Reduction Coalition).
Continuing support of such programs will be essential to reducing barriers to action.
Self-Efficacy
Finally, self-efficacy must also be addressed in order to increase awareness of naloxone.
PSAs and workshops instructing individuals where and how to access naloxone could serve to
increase the American public’s confidence in being able to bring the drug into their household or
place of work. Other programs and flyers could also be designed to demonstrate how to assemble
and administer the drug during an emergency situation. Having these discussions and
instructions integrated into traditional first aid training could also allow individuals to safely
practice giving naloxone under the guidance of a trained professional.
Conclusion
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The United States’ historical relationship with drugs is one built upon fear and
misunderstanding. This complicated connection eventually led to the creation of public health
initiatives designed to decrease drug use that frequently utilized threats of extreme loss and
danger. However, this method of dissuading the American public has not been effective and has
left them overwhelmingly underprepared. The promotion of naloxone ownership to counteract
some of the negative consequences of the opioid epidemic should follow a Health Belief Model
framework in order to successfully appeal to and protect the American people. This approach
will involve acknowledgment of the influence of perceived severity, perceived susceptibility,
barriers to action, benefits to action, and self-efficacy. A shift to public health initiatives modeled
on these five factors will provide a new and empirically-backed approach to a long-existing
issue.
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Appendix A
Questionnaire
Demographic Information
Age: 18-24 25-34 35-44 45-54 55-64 65+
Gender: Female Male Other:_____________ Prefer not to say
Career/Job Title:________________________________________________________
Race/Ethnicity: Asian/Pacific Islander Black or African American Hispanic or Latino
Native American/American Indian White/Caucasian Other Prefer not to say
Highest Education Level: Less than High School High School Graduate Some college
2 year Degree 4 year Degree Doctorate Other

Health Insurance Status (as of today): Insured Uninsured Prefer not to say

Part 1: Pre-Questionnaire
How familiar are you with naloxone (aka Narcan)?
❏ Extremely familiar
❏ Very familiar
❏ Moderately familiar
❏ Slightly familiar
❏ Not familiar at all
Continue to the next question unless you answered “Not familiar at all”. If you were not
familiar at all, skip to Part 2 of the survey.
Where did you learn about naloxone? (Select one or more answers below)
❏ Personal experience
❏ A medical professional
❏ Through work
❏ Through school/educational program
❏ Through media exposure (Television, movies, books, songs, etc.)
❏ A friend
❏ Other:______________
Have you ever been in possession of naloxone?
Yes
No
Maybe
Have you ever administered naloxone to someone else?
Yes
No
Maybe
Has anyone ever administered naloxone to you?
Yes
No
Maybe
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Some helpful information for answering the next section!
Naloxone/Narcan: “a drug administered by injection or as a nasal spray to reverse the effects of
opioids especially in the emergency treatment of opioid overdose”
Opioids: “a natural, semisynthetic, or synthetic substance that typically produces narcotic effects
(such as sedation, pain relief, slowed breathing, and euphoria)”
- Examples of opioids include morphine, heroin, oxycodone, hydrocodone, fentanyl, and
methadone

Part 2
Please rate the following questions with the scores provided by the scale below:
Strongly
Agree

Agree

Somewhat
Agree

Neutral

Somewhat
Disagree

Disagree

Disagree
Strongly

(1)

(2)

(3)

(4)

(5)

(6)

(7)

1.
2.
3.
4.
5.
6.
7.
8.

When the public is educated about a health issue, they are more able to help address it.
I know what to do if someone overdoses on opioids
I believe drug use is a major inhibitor to good health.
I know where to acquire naloxone
When given the opportunity, I enjoy aiding others who are in need.
My chances of a drug overdose are low.
Giving aid to the poor is the right thing to do.
Having access to an anti-opioid drug would let me help others in the event of an
emergency.
9. I can usually handle whatever comes my way.
10. It is generally easy for opioid drugs to be managed and taken safely.
11. If I buy naloxone, people will think that I take drugs.
12. If the person in front of me in the check-out line at a store was a few cents short, I would
pay the difference.
13. Drug overdoses in my community are rare.
14. If more people had naloxone, the negative effects of the opioid epidemic could be greatly
reduced.
15. I expect others to step in and help during an overdose before me.
16. A dose of naloxone will not be helpful for someone experiencing an overdose.
17. It is not my responsibility to help opioid addicts
18. I try to offer my help with any activities my community or school groups are carrying
out.
19. Someone in my neighborhood/community will likely overdose on opioids
20. I believe naloxone will contribute to continued opioid addiction
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21. I am confident that I could deal efficiently with an opioid overdose.
22. The opioid crisis is over-exaggerated.
23. I know how to obtain preventative doses of anti-opioid drugs
24. I dislike giving directions to strangers who are lost.
25. I can easily imagine a family member overdosing on opioids.
26. I believe naloxone would help the person it is given to.
27. Remaining calm in the event of witnessing a drug overdose will be challenging for me.
(reverse code)
28. A drug overdose significantly impacts a person’s life
29. $45 is too much to pay for naloxone.
30. Helping people does more harm than good because they come to rely on others and not
themselves. (reverse code)
31. I will likely overdose on opioids in my lifetime.

(Part 3) End of survey
How interested would you be in learning more about Narcan?
Extremely
Interested

Interested

Somewhat
Interested

Neutral

Somewhat
Uninterested

Uninterested

Extremely
Uninterested

(1)

(2)

(3)

(4)

(5)

(6)

(7)

How important do you think it is for the general public to be aware of Narcan?
Extremely
Important

Important

Somewhat
Important

Neutral

Somewhat
Unimportant

Unimportant

Not at all
Important

(1)

(2)

(3)

(4)

(5)

(6)

(7)

How likely are you to share the information you learned today?
Extremely
Likely

Likely

Somewhat
Likely

Neutral

Somewhat
Unlikely

Unlikely

Extremely
Unlikely

(1)

(2)

(3)

(4)

(5)

(6)

(7)

How likely are you to obtain Narcan after taking this survey?
Extremely
Likely

Likely

Somewhat
Likely

Neutral

Somewhat
Unlikely

Unlikely

Extremely
Unlikely

(1)

(2)

(3)

(4)

(5)

(6)

(7)

Here are some helpful weblinks if you wish to learn more!
How to Get Naloxone without a prescription
https://www.goodrx.com/blog/heres-how-to-get-naloxone-the-opioid-overdose-antidote-withouta-prescription/
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Identifying an Overdose and Instructions on How to Administer Anti-Opioids
https://drugfree.org/article/overdose-response-treatment/
About the Opioid Epidemic in the US
https://www.cdc.gov/injury/features/prescription-drug-overdose/index.html
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Appendix B
Recruitment Message
A Psychological Approach to Public Health Models
My name is Sarah Tilford and I am working on my Honors Thesis in the Department of
Psychological Sciences at the University of San Diego. I am collaborating with my professor, Dr.
Rebekah Wanic, on a study about anti-opioid drugs. We are interested in learning more about
what motivates members of the general public to purchase, learn about, and use these medications.
The study involves a short questionnaire and should take roughly 5-10 minutes of your
time. If you are interested in participating, please click the link below! All responses will remain
anonymous.
If you have any questions, please feel free to contact me: stilford@sandiego.edu
Thank you so much! Your assistance in this study is greatly appreciated.

